India is a country with variety of the medicinal herbs. Quest for safer and natural opinion for treatment of diseases led about 80% of world population to rely on herbal medicine .In advance drug design technology, a large number of drug molecules are being introduced every year but many have bioavailability issues with long lasting side effects. Low bioavailability leads to alteration in therapeutics efficacy of medicaments and cause hindrance encountered during new drug or drug product development .Thus there is need of molecules which when combine with other drugs enhance their bioavailability. Bioenhancers are such agents which by them when combined with active drugs lead to potentiation of pharmacological effect of drug by increasing bioavailability. Natural bioenhancers are the plant based molecules which promote biological activity or uptake of the drugs alone or in combination therapy. Along with piperine as Bioenhancer, proven in many cases there are many other natural constituent which possess Bioenhancer property. There is a vast array of unexploited plants which can be investigated for their drug bioenhancing potency. This article reviewed and emphasizes on the biopotentiator property of Quercetin.Quercetin is a plant pigment (flavonoid), found in many plants and foods, such as onions, green tea, apples and others. Buckwheat tea has a large amount of quercetin. Quercetin also has a as a medicinal benefits.
Cite this article:
Rachana Bhimanwar, Lata Kothapalli, Akshay Khawshi. Quercetin as Natural Bioavailability Modulator: An Overview. Research J. Pharm. and Tech 2020; 13(4):2043-2050. doi: 10.5958/0974-360X.2020.00368.6
1. Dahan A, Miller JM, Amidon GL. “Prediction of solubility and permeability class membership. Provisional BCS classification of worlds top oral drugs”, AAPS. 2009, 11(4): 740-746.
2. Ajazuddin , Alexander A., Qureshi A., Kumari L. , Pramudita V., Sharma M. , Saraf B. “Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients”, Fitoterapia, 2014:1-14.
3. Dudhatra, G.B., Mody, S.K., Awale, M.M., Patel, H.B., Modi, C.M., Kumar, A., Kamani, D.R. and Chauhan, B.N., “A comprehensive review on pharmacotherapeutics of herbal bioenhancers”, The Scientific World Journal, pp.1-33.
4. Shailendra Wadhwa, Sarita Singhal, Swati Rawat. “Bioavailability Enhancement by Piperine: A Review”. Asian Journal of Biomedical and Pharmaceutical Sciences; 2014, 04 (36):1-8.
5. Kesarwani K, Gupta R. “Bioavailability enhancers of herbal origin: An overview”. Asian Pac J Trop Biomed 2013; 3(4):253-266.
6. Kritika Kesarwani and Rajiv Gupta, “Bioavailability enhancers of herbal origin: An overview” Asian Pac J Trop Biomed 2013; 3(4): 253-266
7. Xiao X, Shi D, Liu L, Wang J, Xie X, Kang T, “Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling”. PLoS One. 2011;6(8):e22934
8. Eid HM , Haddad PS, “The Antidiabetic Potential of Quercetin: Underlying Mechanisms.” Curr Med Chem. 2017; 24(4):355-364.
9. Vessal M, Hemmati M, Vasei M, “Antidiabetic effects of quercetin in streptozocin-induced diabetic rats” Comp Biochem Physiol C Toxicol Pharmacol. 2003 Jul;135C(3):357.
10. Dong Kwon Yang and Hyung-Sub Kang, “Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats,” Biomol Ther (Seoul). 2018 Mar; 26(2): 130–138.
11. MohammedBule,AhmedAbdurahman,ShekoufehNikfar,MohammadAbdollahi,MohsenAmini, “Antidiabetic effect of quercetin: A systematic review and meta-analysis of animal studies,” Food and Chemical toxicology,2019,125:494-502.
12. Soheir E kotob*, Alaa H sayed, Safaa H mohamed, Hanaa H ahmed, “Quercetin and ellagic acid in gastric ulcer prevention: An integrated scheme of the potential mechanisms of action from in vivo study,” Asian Journal of Pharmaceutical and Clinical research, 2018, 11(1):2455-3891.
13. Perez-Vizcaino F1, Duarte J, Jimenez R, Santos-Buelga C, Osuna A, “Antihypertensive effects of the flavonoid quercetin,” Pharmacol Rep. 2009 Jan-Feb;61(1):67-75.
14. Abigail J. Larson J. David Symons and Thunder Jalili, “Therapeutic Potential of Quercetin to Decrease Blood Pressure: Review of Efficacy and Mechanisms” American Society for Nutrition. Adv. Nutr. 2012,3: 39–46.
15. Lakhanpal P, Rai DK., “Quercetin: A versatile flavonoid,” Int J Med Update. 2007;2:22–37.
16. Graefe EU, Derendorf H, Veit M (1999). "Pharmacokinetics and bioavailability of the flavonol quercetin in humans" International Journal of Clinical Pharmacology and Therapeutics. 37 (5): 219–33.
17. Williams RJ, Spencer JP, Rice-Evans C (Apr 2004). "Flavonoids: antioxidants or signalling molecules?" Free Radical Biology & Medicine. 36 (7): 838–49.
18. Barnes S, Prasain J, D'Alessandro T, Arabshahi A, Botting N, Lila MA, Jackson G, Janle EM, Weaver CM. "The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems". Food & Function. 2011,2 (5): 235–44.
19. Horbowicz M. “Method of quercetin extraction from dry scales of onion.” Veget. Crops Res. Bull, 2002. 57: 119-124
20. Min-Jung Ko , Chan-Ick Cheigh, Sang-Woo Cho, Myong-Soo Chung, “Subcritical water extraction of flavonol quercetin from onion skin,” Journal of Food Engineering, 2011,102:327–333.
21. M.T. Munir, Hamid Kheirkhah, Saeid Baroutian, Siew Young Quek, Brent R., “Subcritical water extraction of bioactive compounds from waste onion skin,” Young Journal of Cleaner Production 183 (2018).
22. Kumar B, Smita K and Kumar B, “Ultrasound assisted extraction of quercetin from cabbage,” Int J Pharm Sci & Res 2014; 5(9): 3779-83
23. Mi Jang, Leonid Asnin, Shivraj Hariram Nile, Young Soo Keum, Hwang Yeon Kim & Se Won Park, International Journal of Food Science and Technology 2012, 1-7.
24. Shin SC, Choi JS, Li X. “Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats”. Int J Pharm 2006;313:144–9.
25. Dudhatra GB, Modi SK, Awale MM, Patel HB, Modi CM, Kumar A, “A Comprehensive review on Pharmacotherapeutics of herbal bioenhancers.” Scientific World Journal 2012; 1-33.
26. Sarika Narade , Yogesh Pore*, “Optimization of ex vivo permeability characteristics of berberine in presence of quercetin using 32 full factorial design”,Journal of Applied Pharmaceutical Science, 2019, 9(01), 073-082.
27. Manodeep Chakrabortya, *, Mohammed Gulzar Ahmedb , Ananya Bhattacharjee, “Effect of quercetin on myocardial potency of curcumin against ischemia reperfusion induced myocardial toxicity”, Synergy , 2018,7: 25–29.
28. Qingling Zhao, Jinlan Wei & Hongying Zhang, “Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats”, Xenobiotica, 2018, 49(5):1-14.
29. Fei-Fei Jia, Zhi-Rong, “Effects of quercetin on pharmacokinetics of cefprozil in Chinese-Han male volunteers”, Xenobiotica, 2016, 46(10):896-900.
30. Pamela Soledad Bustosa, Romina Deza-Ponzio, “Protective effect of quercetin in gentamicin-induced oxidative stressin vitro and in vivo in blood cells. Effect on gentamicin antimicrobialactivity”, Environmental Toxicology and Pharmacology, 2016, 48, 253–264.
31. Mai Anh Nguyen, Petra Staubach, “The Influence of Single-Dose and Short-Term Administration of Quercetin on the Pharmacokinetics of Midazolam in Humans“, Journal of Pharmaceutical Sciences, 2015,104,3199–3207.
32. Sujatha Samala and Ciddi Veeresham, “Altered Pharmacokinetics and Pharmacodynamics of Glimepiride by the concomitant use of Quercetin in diabetic rats: PK/PD modelling”, Journal of Pharmacy Research 2015,9(8) :525-530.
33. P. Ravindra Babu , K. Naveen Babu , P. L. Haroled Peter , K. Rajesh , and P. Jawahar Babu , “Influence of quercetin on the pharmacokinetics of ranolazine in rats and in vitro models”, Drug Development and Industrial Pharmacy, 2013; 39(6): 873–879.
34. Joo Hyun Lee, Yong-Jun Shin, “Pharmacokinetic Interactions of Clopidogrel with Quercetin,Telmisartan, and Cyclosporine A in Rats and Dogs”, Arch Pharm Res. 2012, 35(10):1831-7.
35. Anup Kale, Sonia Gawande,Swati Kotwal, Shrirang Netke, Waheed Roomi,Vadim Ivanov, Aleksandra Niedzwiecki and Matthias Rath, “Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract”, Phytother. Reserch, 2010, 24: S48–S55.
36. Sang-Chul Shin a, Jun-Shik Choi, “Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats”, International Journal of Pharmaceutics, 2006, 313:144–149.
37. Robert DiCenzo, Valerie Frerichs, “Effect of Quercetin on the Plasma and Intracellular Concentrations of Saquinavir in Healthy Adults,” Pharmacotherapy, 2006, 26(9):1256-1261.
38. Kyoung-Ah Kim, Pil-Whan Park, “Effect of Quercetin on the Pharmacokinetics of Rosiglitazone, a CYP2C8 Substrate in Healthy Subjects”,Journal of Clinical Pharmacology, 2005;45:941-946.
39. J.-S. Choi, X. Li , “Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits,” International Journal of Pharmaceutics 297 (2005): 1–8.
40. Jun-Shik Choi and Hyo-Kyug Han, “The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits”, Journal of Pharmacy and Pharmacology 2004, 56: 1537–1542.
41. Javed, S., Ahsan, W. and Kohli, K., “.The concept of bioenhancers in bioavailability enhancement of drugs–a patent review” ,Journal of Scientific Letters,:143-165.
42. Prakash, S, Kherde, P. and Rangari, V., “Bioenhancement effect of piperine and ginger oleo resin on the bioavailability of atazanvir”. Int. J. Pharmacy and Pharm. Sciences, 2015, pp.241-245.
43. Balakrishnan, V., Varma, S. and Chatterji, D., 2001. Piperine augments transcription inhibitory activity of rifampicin by several fold in Mycobacterium smegmatis. Current Science, pp.1302-1305.
44. Hollman, P.C., Van Trijp, J.M., Buysman, M.N., vd Gaag, M.S., Mengelers, M.J., De Vries, J.H. and Katan, M.B., 1997. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS letters, 418(1-2), pp.152-156.
45. Ow, Y.Y. and Stupans, I., 2003. Gallic acid and gallic acid derivatives: effects on drug metabolizing enzymes. Current Drug Metabolism, pp.241-248.